Approval for a post approval study labeling update.
Device | BD Onclarity HPV Assay |
Classification Name | Kit, Dna Detection, Human Papillomavirus |
Generic Name | Kit, Dna Detection, Human Papillomavirus |
Applicant | BECTON, DICKINSON AND COMPANY |
Date Received | 2019-08-21 |
Decision Date | 2019-11-22 |
PMA | P160037 |
Supplement | S003 |
Product Code | MAQ |
Advisory Committee | Microbiology |
Supplement Type | Normal 180 Day Track No User Fee |
Supplement Reason | Labeling Change - Pas |
Expedited Review | No |
Combination Product | No |
Applicant Address | BECTON, DICKINSON AND COMPANY 7 Loveton Circle sparks, MD 21152 |
Supplemental Filings
Supplement Number | Date | Supplement Type |
P160037 | | Original Filing |
S013 |
2022-11-21 |
30-day Notice |
S012 | | |
S011 |
2022-10-21 |
30-day Notice |
S010 |
2021-10-28 |
Real-time Process |
S009 |
2020-09-14 |
30-day Notice |
S008 | | |
S007 |
2020-07-06 |
30-day Notice |
S006 |
2020-02-21 |
30-day Notice |
S005 | | |
S004 | | |
S003 |
2019-08-21 |
Normal 180 Day Track No User Fee |
S002 |
2019-02-26 |
Real-time Process |
S001 |
2018-04-27 |
135 Review Track For 30-day Notice |
NIH GUDID Devices